000

EUGENE

No trades
See on Supercharts
Market capitalization
‪246.05 B‬KRW
‪65.75 B‬KRW
‪1.47 T‬KRW
‪34.07 M‬
Beta (1Y)
0.50

About EUGENE

CEO
Jong-Seong Choi
Headquarters
Bucheon-si
Employees (FY)
695
Founded
1984
ISIN
KR7023410004
FIGI
BBG000BJ5J08
EUGENE Corp. engages in the manufacture and sale of ready-mixed concrete and asphalt. It operates through the following business divisions: Concrete, Construction Material, Consturction, and the Other. The Concrete division produces ready-mixed concretes and asphalt concretes. The Construction division mainly engages in the housing construction business and others. The company was founded by Jae-Pil Yu on June 13, 1984 and is headquartered in Bucheon-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 023410 is 3525 KRW — it has increased by 1.15% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange EUGENE stocks are traded under the ticker 023410.
023410 stock is 2.31% volatile and has beta coefficient of 0.50. Check out the list of the most volatile stocks — is EUGENE there?
EUGENE revenue for the last quarter amounts to ‪376.40 B‬ KRW despite the estimated figure of ‪458.10 B‬ KRW. In the next quarter revenue is expected to reach ‪393.50 B‬ KRW.
Yes, you can track EUGENE financials in yearly and quarterly reports right on TradingView.
023410 stock has risen by 3.52% compared to the previous week, the month change is a 7.48% fall, over the last year EUGENE has showed a 7.47% increase.
023410 net income for the last quarter is ‪−15.92 B‬ KRW, while the quarter before that showed ‪25.13 B‬ KRW of net income which accounts for −163.37% change. Track more EUGENE financial stats to get the full picture.
Today EUGENE has the market capitalization of ‪238.86 B‬, it has increased by 1.17% over the last week.
Yes, 023410 dividends are paid annually. The last dividend per share was 170.00 KRW. As of today, Dividend Yield (TTM)% is 4.88%. Tracking EUGENE dividends might help you take more informed decisions.
EUGENE dividend yield was 4.93% in 2023, and payout ratio reached 17.73%. The year before the numbers were 4.73% and 30.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 023410 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EUGENE stock right from TradingView charts — choose your broker and connect to your account.
023410 reached its all-time high on Jul 20, 2007 with the price of 20450 KRW, and its all-time low was 1505 KRW and was reached on Jun 3, 2004.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 695.00 employees. See our rating of the largest employees — is EUGENE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EUGENE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EUGENE stock shows the sell signal. See more of EUGENE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EUGENE EBITDA is ‪106.31 B‬ KRW, and current EBITDA margin is 7.21%. See more stats in EUGENE financial statements.